← REGENERON PHARMACEUTICALS, INC.
| Annual Trend | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: | ||||||||||||
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||||||
| Net Income (Loss) Attributable to Parent | $895.5m |
$1.2b
+33.83%
|
$2.4b
+103.95%
|
$2.1b
-13.44%
|
$3.5b
+66.05%
|
$8.1b
+129.86%
|
$4.3b
-46.28%
|
$4.0b
-8.87%
|
$4.4b
+11.61%
|
$4.5b
+2.09%
|
— | |
| Depreciation, Depletion and Amortization | $104.7m | $145.5m | $148.2m | $210.3m | $235.9m | $286.2m | $341.4m | $421.0m | $482.9m | $543.7m | $528.6m | |
| Amortization of Intangible Assets | — | — | — | — | — | — | — | $92.2m | $128.9m | $178.8m | — | |
| Amortization Cash Flow | — | — | — | — | — | — | $37.6m | $92.2m | $128.9m | — | — | |
| Amortization Of Intangibles | — | — | — | — | — | — | $37.6m | $92.2m | $128.9m | — | $128.9m | |
| Deferred Income Tax Expense (Benefit) | ($360.1m) | $319.0m | ($140.0m) | ($130.6m) | $75.6m | ($147.1m) | ($746.4m) | ($837.8m) | ($757.3m) | ($785.4m) | ($801.5m) | |
| Deferred Tax | — | — | — | — | — | — | ($746.4m) | ($837.8m) | ($757.3m) | ($785.4m) | ($801.5m) | |
| Share-based Payment Arrangement, Noncash Expense | $559.9m | $507.3m | $427.4m | $464.3m | $432.0m | $601.7m | $725.0m | $885.0m | $982.8m | $993.7m | $986.7m | |
| Payment, Tax Withholding, Share-based Payment Arrangement | $143.2m | $301.7m | $187.2m | $188.0m | $680.8m | $1.0b | $445.7m | $700.6m | $1.0b | $532.1m | — | |
| Equity Securities without Readily Determinable Fair Value, Impairment Loss, Annual Amount | — | — | — | — | — | — | — | $29.0m | — | — | — | |
| Nonoperating Income (Expense) | ($926k) | ($1.1m) | $19.1m | $219.3m | $233.8m | $379.0m | $119.9m | $152.2m | $789.2m | $1.7b | — | |
| Other Nonoperating Income (Expense) | $6.3m | $24.0m | $47.3m | $249.5m | $290.7m | $436.3m | $179.3m | $225.2m | $844.4m | $1.7b | — | |
| Changes in operating assets and liabilities: | ||||||||||||
| Change In Working Capital | — | — | — | — | — | — | ($243.3m) | ($94.1m) | ($618.3m) | $532.6m | $18.2m | |
| Increase (Decrease) in Accounts Receivable | $143.8m | $362.7m | $268.9m | $473.1m | $1.4b | $1.9b | ($707.8m) | $338.8m | $554.0m | ($498.1m) | ($968.8m) | |
| Change In Receivables | — | — | — | — | — | — | $707.8m | ($338.8m) | ($554.0m) | $498.1m | ($968.8m) | |
| Changes In Account Receivables | — | — | — | — | — | — | $707.8m | ($338.8m) | ($554.0m) | $498.1m | ($968.8m) | |
| Increase (Decrease) in Inventories | $149.8m | $314.2m | $387.9m | $335.5m | $529.4m | $494.3m | $696.5m | $271.7m | $619.7m | $275.3m | ($82.1m) | |
| Inventory Write-down | $14.0m | — | — | $73.8m | $39.2m | $457.1m | $258.7m | $102.3m | $126.3m | $172.9m | — | |
| Change In Inventory | — | — | — | — | — | — | ($696.5m) | ($271.7m) | ($619.7m) | ($275.3m) | ($82.1m) | |
| Other Operating Income (Expense), Net | — | — | — | — | $280.4m | $45.6m | $89.9m | $2.1m | ($53.4m) | $10.0m | — | |
| Net Cash Provided by (Used in) Operating Activities | $1.5b |
$1.3b
-11.29%
|
$2.2b
+67.94%
|
$2.4b
+10.70%
|
$2.6b
+7.74%
|
$7.1b
+170.47%
|
$5.0b
-29.18%
|
$4.6b
-8.39%
|
$4.4b
-3.78%
|
$5.0b
+12.63%
|
$4.7b
-5.98%
|
|
| Cash flows from investing activities: | ||||||||||||
| Capital Expenditure | — | — | — | — | — | — | ($1.6b) | ($926.4m) | ($881.6m) | ($1.2b) | ($1.1b) | |
| Capital Expenditure Reported | $511.9m | $272.6m | $383.1m | $429.6m | $614.6m | $551.9m | ($590.1m) | ($718.6m) | ($755.9m) | ($898.4m) | ($1.1b) | |
| Payments to Acquire Businesses, Net of Cash Acquired | — | — | — | — | — | — | — | $54.9m | $16.5m | $3.3m | ($11.5m) | |
| Payments for (Proceeds from) Other Investing Activities | — | — | $10.0m | $0 | $0 | — | — | — | — | — | — | |
| Net Cash Provided by (Used in) Investing Activities | ($1.0b) | ($1.0b) | ($1.5b) | ($2.0b) | ($70.6m) | ($5.4b) | ($3.8b) | ($3.2b) | ($2.5b) | ($629.1m) | ($704.2m) | |
| Cash flows from financing activities: | ||||||||||||
| Proceeds from Issuance of Long-term Debt | — | — | — | — | $2.0b | $0 | $0 | — | — | — | $0 | |
| Issuance Of Debt | — | — | — | — | — | $0 | $0 | — | — | — | $0 | |
| Long Term Debt Issuance | — | — | — | — | — | $0 | $0 | — | — | — | $0 | |
| Long Term Debt Payments | — | — | — | — | — | $0 | $0 | — | — | — | $0 | |
| Net Issuance Payments Of Debt | — | — | — | — | — | $0 | $0 | — | — | — | $0 | |
| Repayment Of Debt | — | — | — | — | — | $0 | $0 | — | — | — | $0 | |
| Payments for Repurchase of Common Stock | $143.2m | $301.7m | $4.4m | $275.9m | $5.8b | $1.6b | $2.1b | $2.2b | $2.6b | $3.4b | — | |
| Proceeds from Issuance of Common Stock | $126.7m | $240.2m | $114.5m | $211.8m | $2.6b | $1.7b | $1.5b | $1.1b | $1.5b | $635.9m | $756.1m | |
| Common Stock Dividend Paid | — | — | — | — | — | — | — | $0 | $0 | ($370.3m) | ($378.5m) | |
| Common Stock Issuance | — | — | — | — | — | — | $1.5b | $1.1b | $1.5b | $635.9m | $756.1m | |
| Common Stock Payments | — | — | — | — | — | — | ($2.5b) | ($2.9b) | ($3.6b) | ($4.0b) | ($3.9b) | |
| Issuance Of Capital Stock | — | — | — | — | — | — | $1.5b | $1.1b | $1.5b | $635.9m | $756.1m | |
| Net Common Stock Issuance | — | — | — | — | — | — | ($1.0b) | ($1.8b) | ($2.2b) | ($3.3b) | ($3.1b) | |
| Repurchase Of Capital Stock | — | — | — | — | — | — | ($2.5b) | ($2.9b) | ($3.6b) | ($4.0b) | ($3.9b) | |
| Dividends paid | — | — | — | — | — | — | — | $0 | $0 | $370.3m | ($378.5m) | |
| Cash Dividends Paid | — | — | — | — | — | — | — | $0 | $0 | ($370.3m) | ($378.5m) | |
| Proceeds from (Payments for) Other Financing Activities | — | — | — | — | — | — | — | — | ($33.4m) | ($10.3m) | — | |
| Net Other Financing Charges | — | — | — | — | — | — | — | — | ($33.4m) | ($10.3m) | ($10.3m) | |
| Net Cash Provided by (Used in) Financing Activities | ($700.4m) |
($24.4m)
+96.52%
|
($77.1m)
-215.98%
|
($252.1m)
-226.98%
|
($2.0b)
-681.63%
|
($1.0b)
+48.96%
|
($1.0b)
-0.32%
|
($1.8b)
-77.41%
|
($2.2b)
-22.93%
|
($3.7b)
-68.84%
|
($3.5b)
+5.13%
|
|
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | — | — | — | $150.1m | $577.0m | $690.8m | $221.3m | ($381.6m) | ($248.8m) | $634.7m | $2.5b | |
| Beginning Cash Position | — | — | — | — | — | — | $2.9b | $3.1b | $2.7b | $2.5b | $2.0b | |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | — | — | $1.5b | $1.6b | $2.2b | $2.9b | $3.1b | $2.7b | $2.5b | $3.1b | $2.5b | |
| Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | — | — | — | — | — | $0 | $0 | ($400k) | ($700k) | $300k | ($1.9m) | |
| Effect Of Exchange Rate Changes | — | — | — | — | — | — | $0 | ($400k) | ($700k) | $300k | ($1.9m) | |
| Additional Supplementary Disclosures | ||||||||||||
| Additional Supplementary Disclosures | ||||||||||||
| Supplemental disclosure of cash flow information: | ||||||||||||
| Interest Paid, Excluding Capitalized Interest, Operating Activities | $5.5m | $18.7m | $22.3m | $25.0m | $23.2m | $55.8m | $53.7m | $73.1m | $52.6m | $41.6m | — | |
| Income Taxes Paid, Net | $481.4m | $754.8m | $205.6m | $342.3m | $188.1m | $1.2b | $1.5b | $870.3m | $743.0m | $1.3b | — | |
| Additional Financial Items | ||||||||||||
| Equity Securities, FV-NI, Gain (Loss) | — | — | — | — | — | — | — | — | — | $955.6m | — | |
| Equity Securities, FV-NI, Realized Gain (Loss) | — | — | — | — | — | — | — | — | — | $966.2m | — | |
| Equity Securities, FV-NI, Unrealized Gain (Loss) | — | — | ($41.9m) | $118.3m | $196.0m | $386.1m | ($39.8m) | ($237.8m) | $117.7m | ($10.6m) | — | |
| Income Tax Expense (Benefit) | $434.3m | $880.0m | $109.1m | $313.3m | $297.2m | $1.3b | $520.4m | $245.7m | $367.3m | $725.8m | — | |
| Interest Expense Nonoperating | — | — | — | — | — | — | — | — | $55.2m | $43.8m | — | |
| Payments for Repurchase of Warrants | $643.4m | $0 | $0 | — | — | — | — | — | — | — | — | |
| Cash Flow From Continuing Financing Activities | — | — | — | — | — | — | ($1.0b) | ($1.8b) | ($2.2b) | ($3.7b) | ($3.5b) | |
| Cash Flow From Continuing Investing Activities | — | — | — | — | — | — | ($3.8b) | ($3.2b) | ($2.5b) | ($629.1m) | ($704.2m) | |
| Change In Account Payable | — | — | — | — | — | — | ($138.4m) | $598.6m | $735.1m | $736.8m | $1.3b | |
| Change In Cash Supplemental As Reported | — | — | — | — | — | — | $221.3m | ($381.6m) | ($248.8m) | $634.7m | — | |
| Change In Other Working Capital | — | — | — | — | — | — | $32.4m | $37.9m | $227.8m | ($51.7m) | $217.0m | |
| Change In Payable | — | — | — | — | — | — | ($138.4m) | $598.6m | $735.1m | $736.8m | $1.3b | |
| Change In Prepaid Assets | — | — | — | — | — | — | ($148.6m) | ($120.1m) | ($407.5m) | ($375.3m) | ($482.8m) | |
| Changes In Cash | — | — | — | — | — | — | $221.3m | ($381.2m) | ($248.1m) | $634.4m | $452.3m | |
| End Cash Position | — | — | — | — | — | — | $3.1b | $2.7b | $2.5b | $3.1b | $2.5b | |
| Financing Cash Flow | — | — | — | — | — | — | ($1.0b) |
($1.8b)
-77.41%
|
($2.2b)
-22.93%
|
($3.7b)
-68.84%
|
($3.5b)
+5.13%
|
|
| Free Cash Flow | — | — | — | — | — | — | $3.4b | $3.7b | $3.5b | $3.8b | $3.6b | |
| Gain Loss On Investment Securities | — | — | — | — | — | — | $36.8m | $266.4m | ($118.3m) | ($946.1m) | ($643.1m) | |
| Investing Cash Flow | — | — | — | — | — | — | ($3.8b) | ($3.2b) | ($2.5b) | ($629.1m) | ($704.2m) | |
| Net Business Purchase And Sale | — | — | — | — | — | — | ($230.3m) | ($54.9m) | ($16.5m) | ($3.3m) | ($11.5m) | |
| Net Intangibles Purchase And Sale | — | — | — | — | — | — | ($1.0b) | ($207.8m) | ($125.7m) | ($315.3m) | ($185.2m) | |
| Net Investment Purchase And Sale | — | — | — | — | — | — | ($1.9b) | ($2.2b) | ($1.6b) | $587.9m | $405.2m | |
| Net PPE Purchase And Sale | — | — | — | — | — | — | $0 | $0 | $20.1m | $0 | $0 | |
| Operating Gains Losses | — | — | — | — | — | — | $36.8m | $266.4m | ($118.3m) | ($946.1m) | ($643.1m) | |
| Other Non Cash Items | — | — | — | — | — | — | $563.0m | ($100k) | $36.1m | $135.5m | — | |
| Purchase Of Business | — | — | — | — | — | — | ($230.3m) | ($54.9m) | ($16.5m) | ($3.3m) | ($11.5m) | |
| Purchase Of Intangibles | — | — | — | — | — | — | ($1.0b) | ($207.8m) | ($125.7m) | ($315.3m) | ($185.2m) | |
| Purchase Of Investment | — | — | — | — | — | — | ($7.5b) | ($11.6b) | ($16.6b) | ($11.0b) | ($10.3b) | |
| Sale Of Investment | — | — | — | — | — | — | $5.6b | $9.4b | $15.0b | $11.5b | $10.7b | |
| Sale Of PPE | — | — | — | — | — | — | $0 | $0 | $20.1m | $0 | $0 | |
| Stock Based Compensation | — | — | — | — | — | — | $725.0m | $885.0m | $982.8m | $993.7m | $986.7m |
Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.